ILMN Illumina Stock Outlook 2026: Sequencing Monopoly After the GRAIL Unwind
Illumina ILMN stock outlook 2026: post-GRAIL divestiture focus, NovaSeq X consumables cycle, razor-razorblade moat, MGI-Element-Ultima competitive threats, and a framework for US investors in taxable accounts, Roth IRA, and 401(k).
ILMN Illumina DNASequencing